<DOC>
	<DOC>NCT00094770</DOC>
	<brief_summary>The purpose of this investigational study is to determine the safety and effectiveness of an investigational drug in patients with type 2 diabetes mellitus (a specific type of diabetes).</brief_summary>
	<brief_title>An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)</brief_title>
	<detailed_description>The duration of treatment is 104 weeks.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Glipizide</mesh_term>
	<criteria>Patients who are at least 18 years of age and not older than 78 with type 2 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>